Heska to Present at Three Upcoming Institutional Investor Conferences

LOVELAND, Colo., Feb. 23, 2023

• Bank of America Securities 2023 Animal Health Summit, March 2.  Kevin Wilson, Chief Executive Officer and President, will participate in a virtual fireside discussion at 1:20 p.m. ET.  
  
  
• Raymond James Virtual 44^th Annual Institutional Investors Conference, March 7.  Mr. Wilson will present at 2:15 p.m. ET and the presentation will be immediately followed by a question and answer session.
  
  
• Barclays Global Healthcare Conference, March 14.  Catherine Grassman, Executive Vice President, Chief Financial Officer, will participate in a fireside discussion at 3:05 p.m. ET.

Company management will also participate in one-on-one meetings at each event. Event webcasts and presentations can be accessed through the links provided on the Heska Investor Relations website, https://ir.heska.com/events/. For additional information, please contact Heska Investor Relations at investorrelations@heska.com.

About Heska

Heska Corporation (NASDAQ: HSKA) sells, manufactures, markets, and supports diagnostic and specialty products and solutions for veterinary practitioners. Heska's portfolio includes point-of-care diagnostic laboratory instruments and consumables including rapid assay diagnostic products and digital cytology services; point-of-care digital imaging diagnostic products; local and cloud-based data services; practice information management software ("PIMS") and related software and support; reference laboratory testing; allergy testing and immunotherapy; heartworm preventive products; and vaccines. Heska's primary focus is supporting companion animal veterinarians in providing care to their patients. Heska's business is composed of two operating and reportable segments: North America and International. North America consists of the United States, Canada and Mexico. International consists of geographies outside of North America, primarily in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The Company's strategic focus on point-of-care diagnostic laboratory and imaging products is included in both segments. The North America segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory, and the International segment includes PIMS business and veterinary laboratories. For more information, please visit www.heska.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-to-present-at-three-upcoming-institutional-investor-conferences-301754105.html